171 related articles for article (PubMed ID: 36804907)
1. Two-step algorithm-based Clostridioides difficile testing as a tool for antibiotic stewardship.
Dbeibo L; Lucky CW; Fadel WF; Sadowski J; Beeler C; Kelley K; Williams J; Webb D; Kara A
Clin Microbiol Infect; 2023 Jun; 29(6):798.e1-798.e4. PubMed ID: 36804907
[TBL] [Abstract][Full Text] [Related]
2. Using diagnostic stewardship to reduce rates, healthcare expenditures and accurately identify cases of hospital-onset
Solanky D; Juang DK; Johns ST; Drobish IC; Mehta SR; Kumaraswamy M
Infect Control Hosp Epidemiol; 2021 Jan; 42(1):51-56. PubMed ID: 32943129
[TBL] [Abstract][Full Text] [Related]
3. Did Clostridioides difficile testing and infection rates change during the COVID-19 pandemic?
Hawes AM; Desai A; Patel PK
Anaerobe; 2021 Aug; 70():102384. PubMed ID: 34029702
[TBL] [Abstract][Full Text] [Related]
4. A cost of illness comparison for toxigenic Clostridioides difficile diagnosis algorithms in developing countries.
Cançado GGL; Abreu ES; Nardelli MJ; Serwa P; Brachmann M
Anaerobe; 2021 Aug; 70():102390. PubMed ID: 34058377
[TBL] [Abstract][Full Text] [Related]
5. Dual Reporting of Clostridioides difficile PCR and Predicted Toxin Result Based on PCR Cycle Threshold Reduces Treatment of Toxin-Negative Patients without Increases in Adverse Outcomes.
Hitchcock MM; Holubar M; Hogan CA; Tompkins LS; Banaei N
J Clin Microbiol; 2019 Nov; 57(11):. PubMed ID: 31511334
[TBL] [Abstract][Full Text] [Related]
6. Characteristics and outcomes of
Crone AS; Wright LM; Cheknis A; Johnson S; Pacheco SM; Skinner AM
Infect Control Hosp Epidemiol; 2024 Jan; 45(1):57-62. PubMed ID: 37462099
[TBL] [Abstract][Full Text] [Related]
7. The impact of changing reflexive to clinician-ordered
Sullivan EL; Majumdar R; Ortiz C; Riggs PK; Crum-Cianflone NF
Infect Control Hosp Epidemiol; 2020 Jun; 41(6):684-690. PubMed ID: 32279670
[TBL] [Abstract][Full Text] [Related]
8. Changes in the Association Between Diagnostic Testing Method, Polymerase Chain Reaction Ribotype, and Clinical Outcomes From Clostridioides difficile Infection: One Institution's Experience.
Menon A; Perry DA; Motyka J; Weiner S; Standke A; Penkevich A; Keidan M; Young VB; Rao K
Clin Infect Dis; 2021 Nov; 73(9):e2883-e2889. PubMed ID: 32930705
[TBL] [Abstract][Full Text] [Related]
9. Are Clostridioides difficile infections being overdiagnosed in hematopoietic stem cell transplant recipients?
Ford CD; Lopansri BK; Coombs J; Webb BJ; Asch J; Hoda D
Transpl Infect Dis; 2020 Aug; 22(4):e13279. PubMed ID: 32196881
[TBL] [Abstract][Full Text] [Related]
10. The impact of diagnostic stewardship interventions on Clostridiodes difficile test ordering practices and results.
Khuvis J; Alsoubani M; Mae Rodday A; Doron S
Clin Biochem; 2023 Jul; 117():23-29. PubMed ID: 35378064
[TBL] [Abstract][Full Text] [Related]
11. Clinical Significance of Toxigenic Clostridioides difficile Growth in Stool Cultures during the Era of Nonculture Methods for the Diagnosis of C. difficile Infection.
Lee CC; Lee JC; Chiu CW; Tsai PJ; Ko WC; Hung YP
Microbiol Spectr; 2021 Oct; 9(2):e0079921. PubMed ID: 34668727
[TBL] [Abstract][Full Text] [Related]
12. Clinical heterogeneity of patients with stool samples testing PCR+/Tox- from a two-step Clostridium difficile diagnostic algorithm.
Zou J; Leung V; Champagne S; Hinch M; Wong A; Lloyd-Smith E; Nguyen TT; Romney MG; Sharma A; Payne M; Lowe CF
Eur J Clin Microbiol Infect Dis; 2018 Dec; 37(12):2355-2359. PubMed ID: 30238342
[TBL] [Abstract][Full Text] [Related]
13. Reduction in testing and change in testing algorithm associated with decrease in number of nosocomial Clostridioides (Clostridium) difficile infections.
Cook PP; Nichols S; Coogan M; Opera J; DeHart M
Am J Infect Control; 2020 Sep; 48(9):1019-1022. PubMed ID: 32044135
[TBL] [Abstract][Full Text] [Related]
14. Use of diagnostic and antimicrobial stewardship practices to improve
Sullivan KV; Gallagher JC; Leekha S; Morgan DJ; Morita K; Rock C; Claeys KC
Infect Control Hosp Epidemiol; 2022 Jul; 43(7):930-934. PubMed ID: 34376271
[TBL] [Abstract][Full Text] [Related]
15. Healthcare provider diagnostic testing practices for identification of Clostridioides (Clostridium) difficile in children: an Emerging Infections Network survey.
Kociolek LK; Kutty PK; Polgreen PM; Beekmann SE
Infect Control Hosp Epidemiol; 2019 Mar; 40(3):276-280. PubMed ID: 30767829
[TBL] [Abstract][Full Text] [Related]
16. Assessing the Impact of 2-Step Clostridioides difficile Testing at the Healthcare Facility Level.
Turner NA; Krishnan J; Nelson A; Polage CR; Cochran RL; Fike L; Kuhar DT; Kutty PK; Snyder RL; Anderson DJ
Clin Infect Dis; 2023 Oct; 77(7):1043-1049. PubMed ID: 37279965
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic Modality of Clostridioides difficile Infection Predicts Treatment Response and Outcomes in Inflammatory Bowel Disease.
Gupta A; Wash C; Wu Y; Sorrentino D; Nguyen VQ
Dig Dis Sci; 2021 Feb; 66(2):547-553. PubMed ID: 32207033
[TBL] [Abstract][Full Text] [Related]
18. Antibiotic Exposure and Risk for Hospital-Associated Clostridioides difficile Infection.
Webb BJ; Subramanian A; Lopansri B; Goodman B; Jones PB; Ferraro J; Stenehjem E; Brown SM
Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 31964789
[No Abstract] [Full Text] [Related]
19. Antibiotic Stewardship and Inpatient Clostridioides difficile Testing in Solid Organ Transplant Recipients: The Need for Multilevel Checks and Balances.
Kueht M; Kharsa A; Mujtaba M; Kulkarni R; Britt R; Lea AS; Hafiz G; Fair J; Reynoso D
Transplant Proc; 2022 Apr; 54(3):605-609. PubMed ID: 35249732
[TBL] [Abstract][Full Text] [Related]
20. Implementation of a Structured Process for Clinically Indicated Testing for
Kusma M; Little J; Kociolek L
J Pediatr Hematol Oncol Nurs; 2023; 40(3):188-194. PubMed ID: 36691391
[No Abstract] [Full Text] [Related]
[Next] [New Search]
